CClinicalTrials.gg
Status unknownNCT00880035MUSICUpdated Apr 22, 2009

Efficacy of Music on Reduction of Sedative Drugs in Mechanically Ventilated Intensive Care Unit Patients

A Phase 2/3 interventional study of MP3 music program listening in Sedative Drug Consumption and Mechanically Ventilated ICU Patients, sponsored by Université de Sherbrooke. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-04-22.

Sponsored by Université de Sherbrooke · Phase 2/3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2009), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2/3
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Major objective: a three-days interventional cross-over trial [one day music on, one day wash-out, one day music off][two periods of listening/day], to evaluate:

  1. Impact on sedative drug consumption.
  2. Alteration of stress neuropeptide blood concentrations.

Population: mechanically-ventilated ICU patients

The investigators hypothesize the music will decrease the need of sedative drugs and reduce the concentration of neuropeptides in circulation.

Read the detailed description

The study will imply patients mechanically ventilated for more than 3 days, that require sedation with benzodiazepine and narcotics.

There will be two groups both of exposed to music and placebo (headphones without music). The study will be simple blind.

Sedation scale will be followed regularly. Vitals signs and adjustment of sedation will be recorded by the nurse on the ward. Blood test will be taken before and after placement of headphones in the morning. We will measure IL-6, cortisol, copeptin, prolactin, CRP.

We will analyse the total reduction dose of sedation and analgesia on a daily basis. We will consider a fall of 20% of medication to be significative.

02

Conditions studied

  • Sedative Drug Consumption
  • Mechanically Ventilated ICU Patients

Keywords

  • sedative drug
  • stress
  • music
  • mechanical ventilation
  • IL-6
  • cortisol
  • prolactin
  • CRP
  • copeptin
03

In context

Lead sponsor

Université de Sherbrooke is the lead sponsor of 289 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adults older than 18 years old
  • expected time of mechanical ventilation of more than 72 hours
  • sedation needs for a scale of Sedation-Agitation Scale (SAS) more than 1

Exclusion criteria

Exclusion Criteria:

  • hearing impairment
  • pregnancy
  • needs of vasopressin
  • needs of curarisation
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Group A

    Group A: day 1 = music, day 2 = washout, day 3 = headphone without music

    Device: MP3 music program listening

  • Experimental
    Group B

    Group B: day 1 = headphone without music, day 2 = washout, day 3 = music

    Device: MP3 music program listening

Interventions

  • DeviceMP3 music program listening

    3 days with two 1 hour periods of headset music listening (1 day on, 1 day wash-out, 1 day off)

06

What researchers measure

Primary outcomes

  1. sedative drug consumption in mechanically ventilated ICU patients

    Time frame: 3 days

Secondary outcomes

  1. stress neuropeptide blood content evolution with MUSIC listening

    Time frame: 3 days

07

Study locations

1 of 1 sites recruiting
  • CHUS
    Sherbrooke, Quebec J1H 5N4, Canada
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00880035
Lead sponsor
Université de Sherbrooke
Collaborators
Centre de Recherche Clinique CHUS
First posted
Apr 13, 2009
Start date
Dec 2008
Primary completion
Jul 2010 (estimated)
Completion
Dec 2010 (estimated)
Last update
Apr 22, 2009

Study contacts

Olivier Lesur, MD
Contact
olivier.lesur@usherbrooke.ca
(819)346-1110
Catherine St-Pierre, MD
Contact
catherine.st-pierre@usherbrooke.ca
(819)346-1110
Olivier Lesur, MD
principal investigator · CHUS and Université de Sherbrooke

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion